News

Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...
Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer ...
Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys ...